Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Polygenes, risk prediction, and targeted prevention of breast cancer.

Pharoah PD, Antoniou AC, Easton DF, Ponder BA.

N Engl J Med. 2008 Jun 26;358(26):2796-803. doi: 10.1056/NEJMsa0708739.

2.

Polygenic susceptibility to breast cancer: current state-of-the-art.

Ghoussaini M, Pharoah PD.

Future Oncol. 2009 Jun;5(5):689-701. doi: 10.2217/fon.09.29. Review.

3.

Inherited genetic susceptibility to breast cancer.

Chang-Claude J.

IARC Sci Publ. 2001;154:177-90. Review.

PMID:
11220657
4.

Common breast cancer risk variants in the post-COGS era: a comprehensive review.

Maxwell KN, Nathanson KL.

Breast Cancer Res. 2013 Dec 20;15(6):212. doi: 10.1186/bcr3591. Review.

5.

Clinical implications of low-penetrance breast cancer susceptibility alleles.

Freisinger F, Domchek SM.

Curr Oncol Rep. 2009 Jan;11(1):8-14. Review.

PMID:
19080736
7.

Genetic susceptibility to breast cancer.

Bradbury AR, Olopade OI.

Rev Endocr Metab Disord. 2007 Sep;8(3):255-67. Epub 2007 May 17. Review.

PMID:
17508290
8.

Novel approaches to identify low-penetrance cancer susceptibility genes using mouse models.

de Koning JP, Mao JH, Balmain A.

Recent Results Cancer Res. 2003;163:19-27; discussion 264-6. Review.

PMID:
12903840
9.

Genetic susceptibility, predicting risk and preventing cancer.

Pharoah PD.

Recent Results Cancer Res. 2003;163:7-18; discussion 264-6. Review.

PMID:
12903839
10.

Genetic risk of breast cancer.

Nasir A, Shackelford RE, Anwar F, Yeatman TJ.

Minerva Endocrinol. 2009 Dec;34(4):295-309. Review.

PMID:
20046159
11.

The search for low-penetrance cancer susceptibility alleles.

Houlston RS, Peto J.

Oncogene. 2004 Aug 23;23(38):6471-6. Review.

PMID:
15322517
12.

Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?

Ghoussaini M, Pharoah PD, Easton DF.

Am J Pathol. 2013 Oct;183(4):1038-51. doi: 10.1016/j.ajpath.2013.07.003. Epub 2013 Aug 23. Review.

13.

Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice.

Hodgson SV, Morrison PJ, Irving M.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):56-64. Review.

PMID:
15264273
14.

Breast cancer genetics: what we know and what we need.

Nathanson KL, Wooster R, Weber BL.

Nat Med. 2001 May;7(5):552-6. Review. Erratum in: Nat Med 2001 Jun;7(6):749. Nathanson KN [corrected to Nathanson KL].

PMID:
11329055
15.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

16.

Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.

Sapkota Y.

Cytogenet Genome Res. 2014;144(2):77-91. doi: 10.1159/000369045. Epub 2014 Nov 15. Review.

PMID:
25401968
17.

Breast cancer genome-wide association studies: there is strength in numbers.

Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, Russo A.

Oncogene. 2012 Apr 26;31(17):2121-8. doi: 10.1038/onc.2011.408. Epub 2011 Sep 26. Review.

PMID:
21996731
18.

Modifiers of risk of hereditary breast and ovarian cancer.

Narod SA.

Nat Rev Cancer. 2002 Feb;2(2):113-23. Review.

PMID:
12635174
19.

How can polygenic inheritance be used in population screening for common diseases?

Khoury MJ, Janssens AC, Ransohoff DF.

Genet Med. 2013 Jun;15(6):437-43. doi: 10.1038/gim.2012.182. Epub 2013 Feb 14. Review.

Supplemental Content

Support Center